08/14/2025
3:33 PM | Nantahala Capital Management, LLC (Filed by)
Quince Therapeutics (Subject)
| Form SCHEDULE 13G | |
08/05/2025
11:15 PM | Quince Therapeutics (Filer)
| Form EFFECT | |
08/05/2025
4:14 PM | Quince Therapeutics (Filer)
| Form 424B5 | |
07/25/2025
4:07 PM | Quince Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/16/2025
3:30 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
1:20 PM | Quince Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/23/2025
7:43 AM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
7:46 AM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
7:48 AM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
4:25 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
4:33 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/06/2025
4:36 PM | Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:38 PM | Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:52 PM | Quince Therapeutics (Issuer)
RYAN UNA S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:07 PM | Bray June (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:14 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:27 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
7:40 AM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
7:01 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:00 PM | Quince Therapeutics (Filer)
| Form DEF 14A | |
04/23/2025
3:03 PM | Quince Therapeutics (Filer)
| Form DEFA14A | |
04/09/2025
3:01 PM | Quince Therapeutics (Filer)
| Form PRE 14A | |
03/24/2025
4:17 PM | Quince Therapeutics (Filer)
| Form 424B5 | |
03/24/2025
4:21 PM | Quince Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
3:29 PM | Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
| Form SCHEDULE 13G | |
02/11/2025
4:41 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:43 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
4:44 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:29 PM | Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:30 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:32 PM | Bray June (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:33 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:01 PM | Quince Therapeutics (Filer)
| Form 424B5 | |
12/26/2024
11:15 PM | Quince Therapeutics (Filer)
| Form EFFECT | |
12/18/2024
3:03 PM | Quince Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
5:55 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:17 PM | Lamond David (Filed by)
Quince Therapeutics (Subject)
| Form SC 13D | |
11/13/2024
4:09 PM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:15 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free QNCX Stock Alerts